ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0724
0,00%
Bitcoin
64.216,83
0,51%
Brent Oil
82,765
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. PhaseBio Pharmaceuticals Inc (PHAS)

  7. PhaseBio Pharmaceuticals Inc (PHAS) Notícias

PHAS

PhaseBio Pharmaceuticals (PHAS)

PhaseBio Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PHAS
DataHoraFonteTítuloCódigoCompanhia
30/05/202317:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
19/05/202317:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202317:23Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
03/04/202317:06Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
14/02/202319:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
21/12/202208:10Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/11/202217:44Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/10/202209:00Business WirePhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy CodeNASDAQ:PHASPhaseBio Pharmaceuticals Inc
28/09/202213:05TipRanksPhasebio Pharmaceuticals (PHAS) was downgraded to a Hold Rating at NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
15/08/202207:15TipRanksH.C. Wainwright Keeps Their Buy Rating on Phasebio Pharmaceuticals (PHAS)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202217:15TipRanksPhasebio Pharmaceuticals (PHAS) Receives a Buy from NeedhamNASDAQ:PHASPhaseBio Pharmaceuticals Inc
12/08/202209:30Business WirePhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/06/202209:18TipRanks10 Penny Stocks that Could Deliver Exponential ReturnsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
17/05/202207:26TipRanksH.C. Wainwright Thinks Phasebio Pharmaceuticals’ Stock is Going to RecoverNASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202212:55TipRanksAnalysts Offer Insights on Healthcare Companies: Phasebio Pharmaceuticals (PHAS) and Hookipa Pharma (HOOK)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202207:51Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202207:00Business WirePhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for BentracimabNASDAQ:PHASPhaseBio Pharmaceuticals Inc
16/05/202207:00Business WirePhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
22/04/202217:15Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
18/04/202206:35TipRanksAnalysts Offer Insights on Healthcare Companies: Phasebio Pharmaceuticals (PHAS) and InMode (INMD)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
07/04/202217:00Business WirePhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare ConferenceNASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/04/202209:00Business WirePhaseBio Announces Positive Results from Phase 2b Trial for BentracimabNASDAQ:PHASPhaseBio Pharmaceuticals Inc
25/03/202216:15TipRanksNeedham Thinks Phasebio Pharmaceuticals’ Stock is Going to RecoverNASDAQ:PHASPhaseBio Pharmaceuticals Inc
25/03/202207:25TipRanksH.C. Wainwright Reiterates Their Buy Rating on Phasebio Pharmaceuticals (PHAS)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/03/202217:16Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/03/202217:00Business WirePhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
08/03/202210:00Business WirePhaseBio Pharmaceuticals Announces Bentracimab Manufacturing UpdateNASDAQ:PHASPhaseBio Pharmaceuticals Inc
24/02/202218:00Business WirePhaseBio Pharmaceuticals to Participate in the Cowen 42nd Annual Health Care ConferenceNASDAQ:PHASPhaseBio Pharmaceuticals Inc
10/02/202210:00Business WirePhaseBio Announces Bentracimab Phase 2b Trial Data Accepted for Late Breaking Clinical Research Presentation at the 2022 American College of Cardiology (ACC.22) Annual Scientific SessionNASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/02/202211:31Edgar (US Regulatory)Schedule 13gNASDAQ:PHASPhaseBio Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PHAS

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
GOLL4
GOL PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
AZEV4
AZEVEDO PN
BOV
AZUL4
AZUL PN
BOV
PRIO3
PETRORIO ON
BOV
HETA4
HERCULES PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados